Correlation Between Ladangbaja Murni and Diagnos Laboratorium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ladangbaja Murni and Diagnos Laboratorium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ladangbaja Murni and Diagnos Laboratorium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ladangbaja Murni PT and Diagnos Laboratorium Utama, you can compare the effects of market volatilities on Ladangbaja Murni and Diagnos Laboratorium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ladangbaja Murni with a short position of Diagnos Laboratorium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ladangbaja Murni and Diagnos Laboratorium.

Diversification Opportunities for Ladangbaja Murni and Diagnos Laboratorium

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ladangbaja and Diagnos is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Ladangbaja Murni PT and Diagnos Laboratorium Utama in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diagnos Laboratorium and Ladangbaja Murni is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ladangbaja Murni PT are associated (or correlated) with Diagnos Laboratorium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diagnos Laboratorium has no effect on the direction of Ladangbaja Murni i.e., Ladangbaja Murni and Diagnos Laboratorium go up and down completely randomly.

Pair Corralation between Ladangbaja Murni and Diagnos Laboratorium

Assuming the 90 days trading horizon Ladangbaja Murni PT is expected to under-perform the Diagnos Laboratorium. In addition to that, Ladangbaja Murni is 2.2 times more volatile than Diagnos Laboratorium Utama. It trades about -0.09 of its total potential returns per unit of risk. Diagnos Laboratorium Utama is currently generating about -0.13 per unit of volatility. If you would invest  30,800  in Diagnos Laboratorium Utama on September 1, 2024 and sell it today you would lose (8,800) from holding Diagnos Laboratorium Utama or give up 28.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Ladangbaja Murni PT  vs.  Diagnos Laboratorium Utama

 Performance 
       Timeline  
Ladangbaja Murni 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ladangbaja Murni PT has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Diagnos Laboratorium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diagnos Laboratorium Utama has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Ladangbaja Murni and Diagnos Laboratorium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ladangbaja Murni and Diagnos Laboratorium

The main advantage of trading using opposite Ladangbaja Murni and Diagnos Laboratorium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ladangbaja Murni position performs unexpectedly, Diagnos Laboratorium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diagnos Laboratorium will offset losses from the drop in Diagnos Laboratorium's long position.
The idea behind Ladangbaja Murni PT and Diagnos Laboratorium Utama pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.